• 1
    Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transplant. 2004; 10: S3S8.
  • 2
    Roncalli M. Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience. Liver Transplant. 2004; 10: S9S15.
  • 3
    Hirohashi S,Blum HE,Ishak KG, et al. Hepatocellular carcinoma. In: HamiltonSR,AaltonenLA, eds. Pathology and Genetics of Tumours of the Digestive System. 1st ed. Lyon, France: IARC Press; 2000: 159172.
  • 4
    Kojiro M,Roskams T. Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis. 2005; 25: 133142.
  • 5
    Ferrell L,Wright T,Lake J,Roberts J,Ascher N. Incidence and diagnostic features of macroregenerative nodules versus small hepatocellular carcinoma in cirrhotic livers. Hepatology. 1992; 16: 13721381.
  • 6
    Theise ND,Park YN,Kojiro M. Dysplastic nodules and hepatocarcinogenesis. In: LefkowitchJH, ed. Clinics in Liver Disease. Liver Histopathology. Philadelphia, Pa: Saunders; 2002: 497512.
  • 7
    Kondo F,Kondo Y,Nagato Y,Tomizawa M,Wada K. Interstitial tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views. J Gastroenterol Hepatol. 1994; 9: 604612.
  • 8
    Nakano M,Saito A,Yamamoto M,Doi M,Takasaki K. Stromal invasion and blood vessel wall invasion in well differentiated hepatocellular carcinoma. Liver. 1997; 17: 4146.
  • 9
    Wanless IR,Nakashima E,Sherman M. Regression of human cirrhosis. Morphological features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med. 2000; 124: 15991607.
  • 10
    Falkowski O,An HJ,Ianus IA, et al. Regeneration of hepatocyte ‘buds’ in cirrhosis from intrabiliary stem cells. J Hepatol. 2003; 39: 357364.
  • 11
    Roskams TA,Theise ND,Balabaud C, et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology. 2004; 39: 17391745.
  • 12
    International Working Party. Terminology of nodular hepatocellular lesions. Hepatology. 1995; 22: 983993.
  • 13
    Liver Cancer Study Group of Japan. Histological findings. In: Liver Cancer Study Group of Japan, editors. Classification of Primary Liver Cancer. 1st English Edition. Tokyo: Kanehara; 1997: 2837.
  • 14
    Nakashima O,Sugihara S,Kage M,Kojiro M. Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins. Hepatology. 1995; 22: 101105.
  • 15
    Park YN,Yang CP,Fernandez GJ,Cubukcu O,Thung SN,Theise ND. Neoangiogenesis and sinusoidal “capillarization” in dysplastic nodules of the liver. Am J Surg Pathol. 1998; 22: 656662.
  • 16
    Roncalli M,Roz E,Coggi G, et al. The Vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology. 1999; 30: 11741178.
  • 17
    Dhillon AP,Colombari R,Savage K,Scheuer PJ. An immunohistochemical study of the blood vessels within primary hepatocellular tumours. Liver. 1992; 12: 311318.
  • 18
    Kim H,Park C,Han KH, et al. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype. J Hepatol. 2004; 40: 298304.
  • 19
    Capurro M,Wanless IR,Sherman M, et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology. 2003; 125: 8997.
  • 20
    Chuma M,Sakamoto M,Yamazaki K, et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology. 2003; 37: 198207.
  • 21
    Osada T,Nagashima I,Tsuno NH,Kitayama J,Nagawa H. Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma. J Hepatol. 2000; 33: 247253.
  • 22
    Oh BK,Kim YJ,Park YN,Choi J,Kim KS,Park C. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Am J Gastroenterol. 2006; 101: 831838.
    Direct Link: